Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A growing bacterial colony in two dimensions as an active nematic.

Nature communications·2018
Same author

BUN as an Independent Predictor of Post-Hospital-Discharge Mortality among Older Veterans.

The journal of nutrition, health & aging·2018
Same author

Percutaneous rendezvous technique for the management of a bile duct injury.

Radiology case reports·2018
Same author

Particle-size effects in the formation of bicontinuous Pickering emulsions.

Physical review. E, Statistical, nonlinear, and soft matter physics·2015
Same author

Dodecafluoropentane Emulsion (DDFPe) Decreases Stroke Size and Improves Neurological Scores in a Permanent Occlusion Rat Stroke Model.

The open neurology journal·2015
Same author

Dodecafluoropentane emulsion delays and reduces MRI markers of infarction in a rat stroke model: a preliminary report.

Magnetic resonance imaging·2014
Same journal

Nrf2 Activators in Parkinson's Disease: Modulating Mitophagy and Regulating Cuproptosis.

Molecular neurobiology·2026
Same journal

The Molecular Machinery of Synaptic Plasticity and Its Potential Role in the Aetiology of Schizophrenia.

Molecular neurobiology·2026
Same journal

Hypothalamus Amyloid Levels Are Associated with Early Sex-Dependent Alterations in Peripheral Energy Homeostasis in TgF344-AD Rats.

Molecular neurobiology·2026
Same journal

A Dose-Response Study on Human FGF21 to Inhibit Necrosis, Spectrin Breakdown, and to Increase Intracellular Cold Shock Proteins in Cultured Cortical Neurons Subjected to Oxygen-Glucose Deprivation Injury.

Molecular neurobiology·2026
Same journal

Alpha Lipoic Acid Mitigates TBI-Induced Neuroinflammation by Regulating S100B/STIM Signaling via NF-ƙB Pathway.

Molecular neurobiology·2026
Same journal

Edaravone Attenuates Retinal Ganglion Cell Ferroptosis Induced by Ischemia Reperfusion via Inhibiting the p38 MAPK/ATF3 Signaling Pathway.

Molecular neurobiology·2026
See all related articles

Related Experiment Video

Updated: Apr 11, 2026

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model
09:42

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model

Published on: June 4, 2021

3.7K

Dodecafluoropentane Emulsion Extends Window for tPA Therapy in a Rabbit Stroke Model.

W C Culp1, A T Brown, J D Lowery

  • 1Department of Radiology, University of Arkansas for Medical Sciences, Little Rock, AR, 72205, USA, culpwilliamc@uams.edu.

Molecular Neurobiology
|June 10, 2015
PubMed
Summary
This summary is machine-generated.

Dodecafluoropentane emulsion (DDFPe) extends the therapeutic window for tissue plasminogen activator (tPA) in stroke treatment. This oxygen-carrying nanodroplet therapy significantly improves outcomes when administered up to 9 hours post-stroke.

More Related Videos

The Stroke Preclinical Assessment Network Multi-Laboratory Model of Thromboembolic Stroke with Thrombolysis: TE-MCAo
06:38

The Stroke Preclinical Assessment Network Multi-Laboratory Model of Thromboembolic Stroke with Thrombolysis: TE-MCAo

Published on: December 19, 2025

392
Improved Method for the Preparation of a Human Cell-based, Contact Model of the Blood-Brain Barrier
08:40

Improved Method for the Preparation of a Human Cell-based, Contact Model of the Blood-Brain Barrier

Published on: November 12, 2013

17.2K

Related Experiment Videos

Last Updated: Apr 11, 2026

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model
09:42

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model

Published on: June 4, 2021

3.7K
The Stroke Preclinical Assessment Network Multi-Laboratory Model of Thromboembolic Stroke with Thrombolysis: TE-MCAo
06:38

The Stroke Preclinical Assessment Network Multi-Laboratory Model of Thromboembolic Stroke with Thrombolysis: TE-MCAo

Published on: December 19, 2025

392
Improved Method for the Preparation of a Human Cell-based, Contact Model of the Blood-Brain Barrier
08:40

Improved Method for the Preparation of a Human Cell-based, Contact Model of the Blood-Brain Barrier

Published on: November 12, 2013

17.2K

Area of Science:

  • Biomedical Engineering
  • Neuroscience
  • Pharmacology

Background:

  • Current stroke therapies, like tissue plasminogen activator (tPA), have limited efficacy due to narrow treatment windows.
  • Delays in seeking medical attention often exclude patients from timely stroke treatment.
  • Dodecafluoropentane emulsion (DDFPe) nanodroplets demonstrate potential as oxygen carriers and neuroprotective agents.

Purpose of the Study:

  • To investigate if DDFPe can safely extend the therapeutic time window for tPA in a rabbit stroke model.
  • To evaluate the combined efficacy of DDFPe and tPA in improving neurological outcomes and reducing infarct volume.

Main Methods:

  • A rabbit model of ischemic stroke was induced by internal carotid artery occlusion.
  • Animals received either tPA alone, DDFPe plus tPA, or no therapy.
  • DDFPe was administered intravenously starting 1 hour post-stroke, with subsequent doses every 90 minutes for 6 doses.
  • Standard tPA therapy was initiated 9 hours post-stroke in both treatment groups.
  • Neurological Assessment Scores (NAS) and percent stroke volume (%SV) were measured at 24 hours.

Main Results:

  • The DDFPe + tPA group showed significantly improved NAS (p = 0.0015) and reduced %SV (p = 0.0003) compared to controls and tPA alone.
  • Neurological scores were significantly better in the DDFPe + tPA group versus tPA alone (p = 0.0052).
  • Percent stroke volume was significantly reduced in the DDFPe + tPA group compared to tPA alone (p = 0.0018).

Conclusions:

  • Dodecafluoropentane emulsion (DDFPe) significantly extends the therapeutic time window for tPA in treating ischemic stroke.
  • Combined DDFPe and tPA therapy offers superior neuroprotection and functional recovery compared to tPA alone when initiated late after stroke onset.
  • This approach holds promise for increasing the number of patients eligible for effective stroke treatment.